Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network. - Wikidata - wikimedia - TriplyDB

Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network.

Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network.

http://www.wikidata.org/entity/Q36438251

about

Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology Obesity, nutrition, and liver disease in children Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging Autoimmune-like drug-induced liver injury: a review and update for the clinician.Verification of B-lymphocyte activating factor's involvement in the exacerbation of insulin resistance as well as an autoimmune response in patients with nonalcoholic steatohepatitis and patients with HCV-related chronic liver disease Autoimmune Markers Do Not Impact Clinical Presentation or Natural History of Steatohepatitis-Related Liver Disease.Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children.Review article: overlap syndromes and autoimmune liver disease.Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.Nonalcoholic fatty liver disease - current status and future directions.The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases.Natural History of Patients Presenting with Autoimmune Hepatitis and Coincident Nonalcoholic Fatty Liver Disease.B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver disease.Nonalcoholic fatty liver disease: Evolving paradigms.Antismooth muscle and antiactin antibodies are indirect markers of histological and biochemical activity of autoimmune hepatitis.Anti-adipocyte antibody response in patients with non-alcoholic fatty liver disease.The dynamic and clinical significance of autoantibodies and immunoglobulins in liver transplant recipients.Nonalcoholic fatty liver disease and the ongoing role of liver biopsy evaluation.Speculation of the Time-Dependent Change of FIB4 Index in Patients with Nonalcoholic Fatty Liver Disease: A Retrospective Study.Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis

P2860

Q22299426-D45EFA72-5AFC-4669-9BEF-08182A2F7E7D Q26852019-8FA17736-B14C-4860-8B64-5D51D89FFDD5 Q26998471-F450AD71-88C3-48CD-ACC4-B95B5FAA50B9 Q27002523-C746DE44-2931-4007-882A-F72618E078A5 Q27006131-041E9544-73F1-4E30-A527-F616C1AD9F96 Q30276377-0160EB87-6FA5-4D0F-8FED-FABCF7B759D9 Q33795637-EC848AC3-DE4D-4FAE-BA55-AC5D6156A6EF Q36260378-CBA94753-575B-4D26-9A46-646C581CFC43 Q36791363-971FD328-BB59-444C-B767-DBFDEF360193 Q38027909-BE0A972C-03D6-4DB3-9821-7996CCC560C3 Q38128548-7673D0D2-E428-49E4-BBC5-D91B8B036C2C Q38204970-2F946135-AC84-4B72-B795-1320EFBF50AB Q38592767-A9A656AC-A79C-48E3-9A82-E3D46C475D66 Q38676257-AF7CAAE0-6675-4741-9C87-59DCF68D0E7E Q39709297-A85337BD-1EAB-4E99-9A86-65A2C1152AE1 Q40707257-EE78D8CF-6A80-4216-B452-B40B6EFA2B3E Q42695154-BB854F7B-7A8C-4C7A-BF52-85CEEA3A58A3 Q44833785-F55B38C0-3EFF-4A99-8757-6677F9970669 Q45006677-E6C57354-32FF-4DD9-82DE-8A5DE3F42FD9 Q53237682-EFDB73EA-D87F-4F9F-B70B-C08DCD04C06C Q55122484-4F12F97B-1728-4D31-9B8C-EA0C62A4AC40 Q55287849-9B8CF300-0613-44B2-B41C-851FEFFD6335 Q56343202-2B96C39C-A177-45CB-A4F0-D817BC10427A

P2860

Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network.

http://www.wikidata.org/entity/Q36438251

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Clinical significance of serum ...... tis clinical research network.

@ast

Clinical significance of serum ...... tis clinical research network.

@en

type

label

Clinical significance of serum ...... tis clinical research network.

@ast

Clinical significance of serum ...... tis clinical research network.

@en

prefLabel

Clinical significance of serum ...... tis clinical research network.

@ast

Clinical significance of serum ...... tis clinical research network.

@en

P1433

Q36438251-74F73091-809E-4D0B-8E50-ACF01DDD1721

P1476

Q36438251-A623C53B-6DCE-4871-B889-82FF4F6923D7

P2093

Q36438251-2B7EE5F3-E710-4DF2-850B-8C96B4E72F4D

Q36438251-40022233-C212-4F15-B4EC-40E5C40F7E11

Q36438251-5C3EEC3D-C3CF-4B6B-8FA9-41B9A1624A76

Q36438251-6578F533-C014-4A47-9B1A-4E21389115FC

Q36438251-77AFFA09-D21C-40A5-81DB-B9D6FECAA982

Q36438251-8B54321F-FAD4-4F9B-927D-114FFA2AEED2

Q36438251-CA8068E5-CF5E-4D30-8D7D-C59872C752E2

P2860

Q36438251-006DA9B4-6015-4BBB-9D44-30F9F916F4C0

Q36438251-1ABDB21C-689A-48B2-917D-D4ED4DDE1517

Q36438251-1E350B64-D8AF-49EC-B2B4-6CC49959B02F

Q36438251-35DA034F-2E31-422B-9157-C6230288743B

Q36438251-3B0D215A-E18C-40AE-BB71-E1FEC5ED311B

Q36438251-50249A73-4998-4D71-ADCA-6513951DEA9C

Q36438251-63C7EB3E-CEBF-45F5-B44E-EB210AFDA518

Q36438251-6BDEECEA-D0B4-41ED-A79C-09560254FD1F

Q36438251-79508D1F-44FE-4DE9-8B92-A6D72FACEFE0

Q36438251-8E08FBD5-AFC3-42C4-B8C3-A3C06B7F56CE

P2888

Q36438251-9A572914-7AE0-45E4-ADD8-1AE15197CAEB

P304

Q36438251-17F93142-DD9B-4CDC-ACC5-9AD5C893DA95

P31

Q36438251-356FE9D0-1731-466E-9535-9666F3F3F01E

P356

Q36438251-0C7A543F-96FB-46CB-8E54-F995F864F668

P433

Q36438251-C7B6EB0D-7612-48E7-9C29-92063EC1D5E9

P478

Q36438251-462D0329-99EB-4A69-BEC8-D33A2760B940

P50

Q36438251-1B8F1954-F5C7-47F4-879C-C60812CFFFA3

P577

Q36438251-F61DCA23-F0A8-4C15-A39D-5B42EF66C28A

P5875

Q36438251-BA35F856-2A20-44D0-A0F6-138C016A0367

P698

Q36438251-33FA99C7-FA14-4471-922A-90C9B00BD889

P921

Q36438251-71BA40A2-12CB-491E-ADF5-7FEDE2959A5E

Q36438251-B622C37B-D287-4FB8-8001-005BE8BC3354

P932

Q36438251-D724A9B3-C50E-4C47-A684-F622932AD8A7

P356

S12072-011-9277-8

P1433

Hepatology international

P1476

Clinical significance of serum ...... itis clinical research network

@en

P2093

Aynur Unalp-Arida

http://www.w3.org/2001/XMLSchema#string

Kris V Kowdley

http://www.w3.org/2001/XMLSchema#string

Laura A Wilson

http://www.w3.org/2001/XMLSchema#string

Naga Chalasani

http://www.w3.org/2001/XMLSchema#string

Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)

http://www.w3.org/2001/XMLSchema#string

Oscar W Cummings

http://www.w3.org/2001/XMLSchema#string

Robert J Gould

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.

Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.

Range of antinuclear antibodies in "healthy" individuals.

Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design.

Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis.

Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases.

P2888

s12072-011-9277-8

P304

379-385

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12072-011-9277-8

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Raj Vuppalanchi

P577

2011-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51112171

http://www.w3.org/2001/XMLSchema#string

P698

21557024

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

P932

3511661

http://www.w3.org/2001/XMLSchema#string